FREDERICK, Md., June  04, 2026  (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (&#34;TOMI&#34;) (NASDAQ:TOMZ), a global leader in disinfection and decontamination solutions, has secured official regulatory approval

TOMZ

TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology

TOMI's BIT expands EU footprint with Austria and Italy approvals

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>FREDERICK, Md., June  04, 2026  (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (&amp;#34;TOMI&amp;#34;) (NASDAQ:TOMZ), a global leader in disinfection and decontamination solutions, has secured official regulatory approval</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>TOMI announced regulatory clearance for BIT in Austria and Italy, expanding its EU footprint; the Netherlands has PT2 approval since March 2026. Under the EU Biocidal Products Regulation, mutual recognition can speed rollout to France, Ireland, Poland, Portugal, Romania and Spain, potentially lifting near-term European revenue opportunities.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Austria and Italy approve TOMI&#039;s BIT; NL PT2 approved March 2026.</li><li>EU Biocidal Products Regulation enables mutual recognition, speeding EU rollout.</li><li>EU expansion broadens TOMI&#039;s addressable market and potential revenue.</li><li>Mutual recognition expected to bring France, Ireland, Poland, Portugal, Romania, Spain.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>TOMI Environmental Solutions, Inc. (TOMZ)</strong>: EU BIT approvals expand footprint; Netherlands PT2; potential near-term revenue uplift.</li><li><strong>DARPA (N/A)</strong>: Origin of BIT technology; regulatory/technical credibility but no direct stock impact.</li></ul>
  </section>

  <section data-block="category">
    <h3>Industry News</h3>
    <p>Industry News focused on regulatory-driven expansion and its potential impact on TOMZ&#039;s growth trajectory.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>EU mutual recognition could accelerate TOMZ&#039;s EU market rollout.</li><li>Netherlands PT2 approval since March 2026 supports credibility and pipeline.</li><li>Upcoming France/Ireland/Poland/Spain rollouts may broaden addressable revenue.</li><li>Regulatory news may impact sentiment more than immediate cash flows.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Austria and Italy authorized for BIT in June 2026.</li><li>Netherlands PT2 approved in March 2026.</li><li>EU Biocidal Products Regulation enables mutual recognition for faster cross-border approvals.</li><li>TOMI Environmental Solutions trades as NASDAQ:TOMZ.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>EU BIT expansion could drive near-term revenue growth and multiple expansion for TOMZ over the next 6–12 months.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>FREDERICK, Md., June  04, 2026  (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.<sup>&#xAE;</sup> ("TOMI") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/TOMZ">TOMZ</a>), a global leader in disinfection and decontamination solutions, has secured official regulatory approval for its Binary Ionization Technology (BIT) in additional European Union member states. This milestone marks a significant step forward in the Company&#39;s European market expansion, with Austria and Italy joining the list of authorized countries. With these new additions, TOMI's innovative disinfection product is now approved for use in Austria, Italy, the Netherlands, Belgium, Denmark, Germany, Hungary, Great Britain, and Northern Ireland. Notably, the product has been officially authorized as a PT2 disinfectant in the Netherlands since March 2026.</p>  <p>The regulatory milestone was achieved under the European Union's Biocidal Products Regulation (BPR), which standardizes the authorization of biocidal products throughout the EU. Because the BPR allows an approval in one member state to support a streamlined mutual recognition process in others, TOMI can significantly accelerate its market rollout without repeating full, independent authorization procedures in every country. Looking ahead, parallel mutual recognition is anticipated to bring the technology to France, Ireland, Poland, Portugal, Romania, and Spain.</p>  <p align="justify"><strong>About TOMI&#x2122; Environmental Solutions, Inc.: Innovating for a safer world<sup>&#xAE;</sup></strong></p>  <p align="justify">TOMI&#x2122; Environmental Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/TOMZ">TOMZ</a>) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology<sup>&#xAE;</sup> (BIT&#x2122;) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT&#x2122; solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP&#x2122;). Represented by the SteraMist<sup>&#xAE;</sup> brand of products, iHP&#x2122; produces a germ-killing aerosol that works like a visual non-caustic gas.</p>  <p align="justify">TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.</p>  <p align="justify">TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.</p>  <p>For additional information, please visit <a href="https://www.globenewswire.com/Tracker?data=vvnufh1mv8F7kh_2AdYDVnnqF6Jj3oxyiv6yUZ4pnH_oN132nf5wfBUBpwdE4KY6ru1OOjlUe0KZxKGR0QORMPpn8XNHvd_dkAOeX3FfWtU=" rel="nofollow" target="_blank">https://www.steramist.com</a> or contact us at <a href="https://www.globenewswire.com/Tracker?data=--7IRZwh_i2QSoarIRs9sNIhaqy_78qYSO03IXUacbiNskg38KkYUDQCjsJFyL2StzV5a20-jotfUs7uX4eXfWdZAPj0ECCbtuD8_H-_BMJ3jU3bzsIOAaXBbERXk8Twjw8-MOX77FVDvlPno47DZIl5TCBSihhEEOo3QQTGVxf88jQkFtruOkxJMYDF6Z_48_bHjBSHASwtkoyhmgLSKwFko3sOuMlXHTgJ0aozV70=" rel="nofollow" target="_blank">info@tomimist.com</a>.</p>  <p><strong>Forward-Looking Statements </strong></p>  <p>This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management's judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI's products and services to serve the European market. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.</p>  <p>INVESTOR RELATIONS CONTACT:  </p>  <p>John Nesbett/Zach Nevas</p>  <p>IMS Investor Relations  </p>  <p><a href="https://www.globenewswire.com/Tracker?data=cZgqG8xwB3v8LLqrwkLnzr7EZ7nftGWshFxWxUEJwD6aKIhRWnR5S3TjLxoJPwwL2LlCvptayPOhyBV-5ooswg6pXkAYn-UkZJZ9l9U53LDf74rMRMeX4OeRT4_u-9rR" rel="nofollow" target="_blank">tomi@imsinvestorrelations.com</a>  </p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTczMjE3NiM3NjM3NTg3IzIwMjc1MzM="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/M2IwNDExOGUtOGU5NS00ZTAzLWE2ZDYtODUwZGYzMGVhNjI2LTEwMzk3MzUtMjAyNi0wNi0wNC1lbg==/tiny/TOMI-Environmental-Solutions-I.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/f8c7c513-0121-4507-84b7-3680626d9cf3"><img src="https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg" border="0" width="150" height="73" alt="Primary Logo"></img></a></p>

TOMI announced regulatory clearance for BIT in Austria and Italy, expanding its EU footprint; the Netherlands has PT2 approval since March 2026. Under the EU Biocidal Products Regulation, mutual recognition can speed rollout to France, Ireland, Poland, Portugal, Romania and Spain, potentially lifting near-term European revenue opportunities.

TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Industry News

Related News